Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Pfizer
NiKang Therapeutics, Inc.
Yuri Semenyuk Rivne Regional Clinical Hospital
Endeavor Health
NiKang Therapeutics, Inc.
University of Minnesota
Johns Hopkins University
Karyopharm Therapeutics Inc
Karolinska Institutet
Mabwell (Shanghai) Bioscience Co., Ltd.
Elucida Oncology
Federico II University
Advaxis, Inc.
Kaiser Permanente
Imperial College London
National Institutes of Health Clinical Center (CC)
Genexine, Inc.
Campus Bio-Medico University
GlaxoSmithKline